Dr. Asnat Raziel

My articles

My articles

Wegovy and binge eating: a controlled trial found less loss of control and better body image

Wegovy and binge eating: what a new controlled trial found

Wegovy and binge eating come up together often in my clinic. Many patients worry that a weight-loss injection will deepen their focus on food and body, or even trigger an eating disorder. A new controlled trial from the University of Pennsylvania offers an encouraging answer. Semaglutide, the active ingredient in Wegovy, reduced loss of control over eating and improved body image compared with placebo.

What’s more, participants who started the trial with binge episodes were much more likely to stop them completely. Still, the researchers saw a few cases of disordered eating behaviors. That is why they recommend periodic monitoring.

What the trial tested

The trial was led by Dr. Kelly Allison, with Prof. Thomas Wadden and Dr. Jena Tronieri, of the Center for Weight and Eating Disorders at the University of Pennsylvania’s Perelman School of Medicine. It was published on November 15 in the International Journal of Eating Disorders.

The team enrolled 120 adults seeking obesity treatment, with a BMI over 27. Participants were randomized 3:2 to semaglutide 2.4 mg weekly or placebo. In addition, everyone received lifestyle counseling on diet and physical activity. Treatment lasted 60 weeks.

Assessments took place at baseline and at weeks 20, 40 and 60. First, clinicians evaluated binge eating and eating disorder symptoms in a structured interview. Participants also completed questionnaires on loss of control over eating, drive for thinness, body dissatisfaction and mood.

Results: Wegovy and binge eating after 60 weeks

At several time points, the semaglutide group improved significantly more than the placebo group on these measures:

  • Loss of control over eating.
  • Overall eating disorder symptoms.
  • Weight and shape concern.
  • Drive for thinness.
  • Body dissatisfaction.

On the other hand, across all participants, the drop in binge frequency did not differ significantly between groups. The picture changed in the subgroups, though. Thirty-one participants reported binge episodes at the start, and 18 had full or subthreshold binge-eating disorder. In both groups, those on semaglutide were more likely to reach full abstinence from binge episodes.

Meanwhile, an earlier report from the same trial found an average weight loss of 15.1% with semaglutide, compared with 3.4% with placebo, at 60 weeks.

Wegovy and binge eating: what about safety

The main concern is that an appetite-suppressing drug could encourage extreme restriction or compensatory behaviors. In this study, reliable worsening of symptoms was rare. New binge eating or compensatory behaviors, such as vomiting, were also rare. Symptom emergence did not seem higher with semaglutide.

Even so, these behaviors did occur in a few people. For that reason, the researchers advise periodic monitoring of at-risk patients. I wrote about screening before treatment in my article on eating disorders and obesity.

Study limitations

The trial was relatively small, and the number of participants with binge episodes was smaller still. So the subgroup findings are an important signal, not proof. In addition, participants were seeking obesity care, not eating disorder treatment. The researchers themselves call for larger studies. According to the announcement of the earlier report, the trial was partly supported by a Novo Nordisk research grant, and the company had no role in the study.

Wegovy and binge eating: infographic of the randomized trial results

What it means for patients

The reassuring finding is that the drug did not appear to increase disordered eating, and it even improved how people related to food and their bodies. This fits what we see in the clinic: less food noise and less inner struggle around the plate.

Keep in mind: Wegovy is not approved to treat binge-eating disorder, either in Israel or in the United States. In both countries, it is approved for obesity and for overweight with related health conditions. A diagnosed eating disorder needs dedicated treatment, not just a weight-loss drug.

What you can do today

Recognize the problem

First, ask yourself honestly: do you eat a large amount in a short time, feeling you can’t stop? Do you eat in secret, or criticize your body harshly? If so, tell your doctor before starting treatment. A short screening questionnaire and an open conversation are the first step.

Team care for Wegovy and binge eating

At our center, care is built as a team. A psychologist treats emotional eating and body image with cognitive behavioral therapy. Meanwhile, a dietitian builds regular meals, without the skipped meals that feed the restrict-and-binge cycle. The physician adjusts medication when needed and evaluates whether bariatric surgery fits.

Habits that help this week

  • Three regular meals a day, with protein, vegetables and legumes.
  • Strength training two to three times a week, plus 150 minutes of aerobic activity a week.
  • Seven hours of sleep a night: fatigue increases hunger and emotional eating.
  • Stress relief, such as walking, breathing exercises or talking with someone close.
  • Regular follow-up with your care team, even when weight is coming down nicely.

In Israel, injectable GLP-1 medications such as Wegovy and Mounjaro are available by prescription today. It’s also worth reading about mental health after weight loss.

The bottom line on Wegovy and binge eating

The Penn trial shows that semaglutide can improve people’s relationship with food and their bodies, not just the number on the scale. In the end, Wegovy and binge eating are not at odds, as long as care includes screening, psychological support and close follow-up.

This article is general information and does not replace personal medical advice.

References

Disordered Eating Attitudes and Behaviors in Individuals With BMI > 27 kg/m2 Treated by Semaglutide: A 60-Week Randomized Placebo-Controlled Trial

Semaglutide May Improve Eating Behaviors and Body Image

Study: Semaglutide Sustains Lower Calorie Intake for More Than a Year

Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effects

Wegovy and binge eating: a young couple enjoying a balanced lunch on a sunny balcony

Dr. Asnat Raziel